VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
5.28
+0.71 (15.54%)
Mar 28, 2024, 4:00 PM EDT - Market closed

VistaGen Therapeutics Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016201520142013 2012 - 2010
Revenue
-0.231.111.090001.25000
Upgrade
Revenue Growth (YoY)
-1.78%--------
Upgrade
Gross Profit
-0.231.111.090001.25000
Upgrade
Selling, General & Admin
14.6613.487.17.437.466.446.2913.924.342.55
Upgrade
Research & Development
44.3835.4111.9313.3717.17.765.23.932.432.48
Upgrade
Operating Expenses
59.0448.8919.0220.824.5614.211.517.856.785.03
Upgrade
Operating Income
-59.27-47.78-17.93-20.8-24.56-14.2-10.25-17.85-6.78-5.03
Upgrade
Interest Expense / Income
00000.010.0100.774.551.5
Upgrade
Other Expense / Income
-0.03-0.02-0-0.030.020.14-28.62.56-3.57
Upgrade
Pretax Income
-59.24-47.76-17.93-20.77-24.59-14.34-10.25-47.22-13.88-2.97
Upgrade
Income Tax
0.01000000000
Upgrade
Net Income
-59.25-47.76-17.93-20.77-24.59-14.35-10.26-47.22-13.89-2.97
Upgrade
Preferred Dividends
00.9524.391.261.141.231.374.200
Upgrade
Net Income Common
-59.25-48.71-42.32-22.04-25.73-15.58-11.62-51.42-13.89-2.97
Upgrade
Shares Outstanding (Basic)
7732100000
Upgrade
Shares Outstanding (Diluted)
773-1000--
Upgrade
Shares Change
5.45%129.85%79.58%67.92%105.63%84.42%326.01%19.98%26.15%29.01%
Upgrade
EPS (Basic)
-8.51-7.38-14.70-15.00-27.00-33.60-46.20-872.41-315.90-81.00
Upgrade
EPS (Diluted)
-8.51-7.38-14.70-15.00-27.00-33.60-46.20-872.41-318.30-114.30
Upgrade
Free Cash Flow
-49.93-45.46-12.35-15.76-14.7-9.06-7.5-4.83-2.77-2.14
Upgrade
Free Cash Flow Per Share
-7.17-6.89-4.30-9.86-15.44-19.57-29.88-82.04-56.37-54.85
Upgrade
Gross Margin
-100.00%100.00%---100.00%---
Upgrade
Operating Margin
--4308.68%-1646.06%----819.88%---
Upgrade
Profit Margin
--4392.42%-3884.33%----929.89%---
Upgrade
Free Cash Flow Margin
--4099.28%-1133.45%----600.10%---
Upgrade
EBITDA
-58.71-47.05-17.45-20.67-24.49-14.25-10.19-46.39-9.28-1.41
Upgrade
EBITDA Margin
--4242.75%-1602.02%----815.49%---
Upgrade
Depreciation & Amortization
0.530.710.480.10.090.080.050.050.060.05
Upgrade
EBIT
-59.24-47.76-17.93-20.77-24.58-14.33-10.25-46.45-9.33-1.46
Upgrade
EBIT Margin
--4306.88%-1645.86%----819.88%---
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).